questionsmedicales.fr
Maladies du système stomatognathique
Maladies des dents
Hypercémentose
Hypercémentose : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hypercémentose : Questions médicales les plus fréquentes",
"headline": "Hypercémentose : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hypercémentose : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-13",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hypercémentose"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies des dents",
"url": "https://questionsmedicales.fr/mesh/D014076",
"about": {
"@type": "MedicalCondition",
"name": "Maladies des dents",
"code": {
"@type": "MedicalCode",
"code": "D014076",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C07.793"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Hypercémentose",
"alternateName": "Hypercementosis",
"code": {
"@type": "MedicalCode",
"code": "D006936",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kamil Górski",
"url": "https://questionsmedicales.fr/author/Kamil%20G%C3%B3rski",
"affiliation": {
"@type": "Organization",
"name": "Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Izabela Polkowska",
"url": "https://questionsmedicales.fr/author/Izabela%20Polkowska",
"affiliation": {
"@type": "Organization",
"name": "Department and Clinic of Animal Surgery, Faculty of Veterinary Medicine, University of Life Sciences, 20-950 Lublin, Poland."
}
},
{
"@type": "Person",
"name": "Bernard Turek",
"url": "https://questionsmedicales.fr/author/Bernard%20Turek",
"affiliation": {
"@type": "Organization",
"name": "Department of Large Animal Diseases and Clinic, Institute of Veterinary Medicine, Warsaw University of Life Sciences, 02-787 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Andrzej Bereznowski",
"url": "https://questionsmedicales.fr/author/Andrzej%20Bereznowski",
"affiliation": {
"@type": "Organization",
"name": "Division of Veterinary Epidemiology and Economics, Institute of Veterinary Medicine, Warsaw University of Life Sciences, Nowoursynowska 159c, 02-776 Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Bruno Maureille",
"url": "https://questionsmedicales.fr/author/Bruno%20Maureille",
"affiliation": {
"@type": "Organization",
"name": "Univ. Bordeaux, CNRS, Ministère de la Culture, PACEA, UMR 5199, F-33600 Pessac, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Roles of long noncoding RNA in triple-negative breast cancer.",
"datePublished": "2023-10-05",
"url": "https://questionsmedicales.fr/article/37795578",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cam4.6600"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA CLAN promotes lymphangiogenesis in the colorectal carcinoma.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36301367",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00428-022-03439-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36528049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cca.2022.12.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.",
"datePublished": "2022-08-30",
"url": "https://questionsmedicales.fr/article/36042115",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02914-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "The crucial roles of long noncoding RNA SNHGs in lung cancer.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36008615",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02909-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système stomatognathique",
"item": "https://questionsmedicales.fr/mesh/D009057"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies des dents",
"item": "https://questionsmedicales.fr/mesh/D014076"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypercémentose",
"item": "https://questionsmedicales.fr/mesh/D006936"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hypercémentose - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hypercémentose",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hypercémentose",
"description": "Comment diagnostiquer l'hypercémentose ?\nQuels examens sont nécessaires pour confirmer l'hypercémentose ?\nQuels signes radiographiques indiquent l'hypercémentose ?\nL'hypercémentose est-elle visible à l'œil nu ?\nPeut-on confondre l'hypercémentose avec d'autres conditions ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=RNA,+Long+Noncoding&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hypercémentose",
"description": "Quels sont les symptômes de l'hypercémentose ?\nL'hypercémentose provoque-t-elle des douleurs ?\nY a-t-il des signes cliniques visibles ?\nL'hypercémentose affecte-t-elle la mastication ?\nPeut-on avoir des gencives enflammées avec l'hypercémentose ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=RNA,+Long+Noncoding&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hypercémentose",
"description": "Comment prévenir l'hypercémentose ?\nLes visites chez le dentiste aident-elles à prévenir l'hypercémentose ?\nUne alimentation saine peut-elle prévenir l'hypercémentose ?\nLe tabagisme influence-t-il l'hypercémentose ?\nLes traitements orthodontiques affectent-ils l'hypercémentose ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=RNA,+Long+Noncoding&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hypercémentose",
"description": "Quel traitement est recommandé pour l'hypercémentose ?\nDes médicaments sont-ils nécessaires pour l'hypercémentose ?\nQuand faut-il envisager une intervention chirurgicale ?\nL'hypercémentose nécessite-t-elle un suivi régulier ?\nPeut-on prévenir l'hypercémentose par des soins dentaires ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=RNA,+Long+Noncoding&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hypercémentose",
"description": "Quelles complications peuvent survenir avec l'hypercémentose ?\nL'hypercémentose peut-elle entraîner des infections ?\nPeut-on perdre des dents à cause de l'hypercémentose ?\nL'hypercémentose affecte-t-elle la santé générale ?\nDes douleurs chroniques peuvent-elles résulter de l'hypercémentose ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=RNA,+Long+Noncoding&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hypercémentose",
"description": "Quels sont les facteurs de risque de l'hypercémentose ?\nL'âge influence-t-il le risque d'hypercémentose ?\nLes maladies systémiques augmentent-elles le risque ?\nLe stress a-t-il un impact sur l'hypercémentose ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D006936?mesh_terms=RNA,+Long+Noncoding&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hypercémentose ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par radiographies dentaires montrant un épaississement du ciment."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour confirmer l'hypercémentose ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens cliniques et des radiographies sont nécessaires pour évaluer l'état des dents."
}
},
{
"@type": "Question",
"name": "Quels signes radiographiques indiquent l'hypercémentose ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "On observe un épaississement du cimentum sur les radiographies, souvent autour des racines."
}
},
{
"@type": "Question",
"name": "L'hypercémentose est-elle visible à l'œil nu ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle nécessite des radiographies pour être détectée, car elle est asymptomatique au début."
}
},
{
"@type": "Question",
"name": "Peut-on confondre l'hypercémentose avec d'autres conditions ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec d'autres maladies parodontales, nécessitant un diagnostic précis."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de l'hypercémentose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypercémentose est souvent asymptomatique, mais peut causer des douleurs dentaires dans certains cas."
}
},
{
"@type": "Question",
"name": "L'hypercémentose provoque-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est généralement asymptomatique, mais des douleurs peuvent survenir si des complications se développent."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques visibles ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'y a pas de signes cliniques visibles, mais des radiographies peuvent montrer des anomalies."
}
},
{
"@type": "Question",
"name": "L'hypercémentose affecte-t-elle la mastication ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, elle n'affecte pas la mastication, sauf si elle entraîne des complications dentaires."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des gencives enflammées avec l'hypercémentose ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypercémentose elle-même ne cause pas d'inflammation des gencives, mais des maladies parodontales peuvent coexister."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hypercémentose ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène bucco-dentaire et consulter régulièrement un dentiste aide à prévenir."
}
},
{
"@type": "Question",
"name": "Les visites chez le dentiste aident-elles à prévenir l'hypercémentose ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des visites régulières permettent de détecter précocement les problèmes dentaires et d'agir."
}
},
{
"@type": "Question",
"name": "Une alimentation saine peut-elle prévenir l'hypercémentose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée contribue à la santé dentaire, mais ne prévient pas spécifiquement l'hypercémentose."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il l'hypercémentose ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme peut aggraver les problèmes parodontaux, augmentant le risque d'hypercémentose."
}
},
{
"@type": "Question",
"name": "Les traitements orthodontiques affectent-ils l'hypercémentose ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements orthodontiques peuvent parfois exacerber l'hypercémentose, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé pour l'hypercémentose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend des symptômes; souvent, aucune intervention n'est nécessaire si asymptomatique."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils nécessaires pour l'hypercémentose ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Généralement, aucun médicament n'est requis, sauf en cas de douleur ou d'infection associée."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une intervention chirurgicale ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une intervention chirurgicale est rare et envisagée uniquement si des complications graves surviennent."
}
},
{
"@type": "Question",
"name": "L'hypercémentose nécessite-t-elle un suivi régulier ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier est conseillé pour surveiller l'évolution et prévenir d'éventuelles complications."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'hypercémentose par des soins dentaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins dentaires réguliers peuvent aider à prévenir les maladies parodontales qui aggravent l'hypercémentose."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'hypercémentose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des douleurs dentaires, des infections ou des problèmes de mastication."
}
},
{
"@type": "Question",
"name": "L'hypercémentose peut-elle entraîner des infections ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, si elle est associée à des maladies parodontales, le risque d'infection augmente."
}
},
{
"@type": "Question",
"name": "Peut-on perdre des dents à cause de l'hypercémentose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, si elle est associée à des maladies parodontales, cela peut entraîner une perte dentaire."
}
},
{
"@type": "Question",
"name": "L'hypercémentose affecte-t-elle la santé générale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "En général, l'hypercémentose n'affecte pas la santé générale, mais des complications dentaires peuvent avoir un impact."
}
},
{
"@type": "Question",
"name": "Des douleurs chroniques peuvent-elles résulter de l'hypercémentose ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs chroniques peuvent survenir si des complications dentaires se développent."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'hypercémentose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des maladies parodontales, des traitements orthodontiques et le tabagisme."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'hypercémentose ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque d'hypercémentose augmente avec l'âge en raison de l'usure dentaire et des maladies parodontales."
}
},
{
"@type": "Question",
"name": "Les maladies systémiques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies systémiques, comme le diabète, peuvent augmenter le risque d'hypercémentose."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur l'hypercémentose ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut contribuer à des comportements nuisibles pour la santé dentaire, augmentant le risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de problèmes dentaires peuvent augmenter le risque d'hypercémentose."
}
}
]
}
]
}
Long noncoding RNAs (lncRNAs) play crucial roles in regulating various hallmarks in cancers. Triple-negative (Estrogen receptor, ER; Human epidermal growth factor receptor 2, HER2; Progesterone recept...
We reviewed the current literature on the roles of lncRNAs in the pathogenesis, therapy resistance, and prognosis of patients with TBNC....
LncRNAs are associated with TNBC pathogenesis, therapy resistance, and prognosis. For example, lncRNAs such as small nucleolar RNA host gene 12 (SNHG12), highly upregulated in liver cancer (HULC) HOX ...
In this review, we outline the functions of various lncRNAs along with their molecular mechanisms involved in the pathogenesis, therapeutic resistance of TBNC. Also, the prognostic implications of lnc...
Metastasis is the main cause of colorectal cancer (CRC)-related death and lymph node plays a vital role in this process. Long noncoding RNAs (lncRNAs) are emerging as an important factor of biological...
Long non-coding RNAs (LncRNAs) are single-stranded RNAs over 200 nucleotides in length that have no protein-coding function and have long been considered non-functional by-products of transcription. R...
Gynecologic cancers are reproductive disorders characterized by pelvic pain and infertility. The identification of new predictive markers and therapeutic targets for the treatment of gynecologic cance...
Lung cancer is one of the most common malignant tumors with growing morbidity and mortality worldwide. Several treatments are used to manage lung cancer, including surgery, radiotherapy and chemothera...
The main pathological change of myocarditis is an inflammatory injury of cardiomyocytes. Long noncoding RNAs (lncRNAs) are closely related to inflammation, and our previous study showed that different...
RNA expression was measured by quantitative reverse-transcription polymerase chain reaction (RT-qPCR). Lipopolysaccharide (LPS) was used to induce inflammation in human cardiomyocytes (HCMs). The expr...
NONHSAT122636.2 was dynamically expressed in patients with myocarditis and negatively correlated with inflammation severity. The overexpression of NONHSAT122636.2 improved inflammatory injury in LPS-s...
NONHSAT122636.2 attenuates myocardial inflammation and apoptosis in myocarditis. Additionally, its expression decreases in the peripheral blood of children suffering from myocarditis and in patients w...
IgA nephropathy (IgAN) is one of the most common primary glomerular diseases worldwide, especially in young Asian adults. Long RNA H19 is associated with renal pathologies, such as renal cell injury; ...
Our cohort consisted of 204 patients with IgAN. Serum H19 levels were determined with reverse-transcription quantitative polymerase between 1 May, 2014 and 1 May, 2015. H19 levels were log-transformed...
H19 expression was significantly downregulated in patients with IgAN compared to healthy controls. Restricted cubic spline analyses showed that the relationship was negatively and linearly correlated ...
H19 is an independent protective factor, and a high level of H19 often indicates better renal outcome within 5 years....
Increasing evidence has demonstrated that high TTN-AS1 expression is highly related to poor prognosis in diverse human cancers. However, the findings concerning the prognostic value of TTN-AS1 were in...
Web of Science, Springer, Embase, PubMed, Cochrane Library, and Scopus databases were comprehensively searched to retrieve studies related to the TTN-AS1 expression with the prognosis of malignancies....
Twenty studies involving 17 different cancers and 1330 patients were recruited into this meta-analysis. The research revealed that high TTN-AS1 expression was remarkably associated with unfavorable ov...
The results of this meta-analysis support that high TTN-AS1 expression significantly correlates with worse prognosis in various cancers. Therefore, TTN-AS1 may be considered as a novel biomarker for m...
Macrophages play an essential role in maintaining the normal function of the innate and adaptive immune responses during host defence. Macrophages acquire diverse functional phenotypes in response to ...
Cancer has become the most common life-threatening disease in the world. Cancers presenting with advanced stages and metastasis show poor prognosis, even with the application of radiotherapy, surgery,...